MATTHEW LANGSTON

Allopathic & Osteopathic Physicians|Internal Medicine|Interventional Cardiology LANCASTER, PA NPI 1609371202

General Payments — all program years on this page

$1,649.36

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 38
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $735.99 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $735.9920

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $71.921
2023 $841.4517
2024 $735.9920

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086990636 Novartis Pharmaceuticals Corporation $17.45 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086990642 Novartis Pharmaceuticals Corporation $19.27 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086990652 Novartis Pharmaceuticals Corporation $18.84 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086990654 Novartis Pharmaceuticals Corporation $21.06 11/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092230575 Boston Scientific Corporation $149.61 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101659409 E.R. Squibb & Sons, L.L.C. $25.57 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101659420 E.R. Squibb & Sons, L.L.C. $19.56 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101659449 E.R. Squibb & Sons, L.L.C. $14.10 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101659467 E.R. Squibb & Sons, L.L.C. $21.39 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110514714 AstraZeneca Pharmaceuticals LP $84.72 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116874429 Medtronic, Inc. $31.06 08/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118077794 Boehringer Ingelheim Pharmaceuticals, Inc. $14.76 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1122123045 Abbott Laboratories $22.96 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1122123892 Abbott Laboratories $25.80 09/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131395469 PFIZER INC. $25.99 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131395473 PFIZER INC. $21.09 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139937595 GENZYME CORPORATION $35.00 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140126981 Inari Medical, Inc. $122.18 12/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151765417 Terumo Medical Corporation $20.83 09/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154876793 Kiniksa Pharmaceuticals International, plc $24.75 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.